Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.
2.

Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials.

de Bruin M, Viechtbauer W, Schaalma HP, Kok G, Abraham C, Hospers HJ.

Arch Intern Med. 2010 Feb 8;170(3):240-50. doi: 10.1001/archinternmed.2009.536. Review.

PMID:
20142568
3.

Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.

Hart JE, Jeon CY, Ivers LC, Behforouz HL, Caldas A, Drobac PC, Shin SS.

J Acquir Immune Defic Syndr. 2010 Jun;54(2):167-79. doi: 10.1097/QAI.0b013e3181d9a330. Review. Erratum in: J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):e37-8.

4.

Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.

Haddad M, Inch C, Glazier RH, Wilkins AL, Urbshott G, Bayoumi A, Rourke S.

Cochrane Database Syst Rev. 2000;(3):CD001442. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD001442.

PMID:
10908497
5.

Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.

Rueda S, Park-Wyllie LY, Bayoumi AM, Tynan AM, Antoniou TA, Rourke SB, Glazier RH.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD001442. Review.

PMID:
16855968
6.

Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy.

Tuldrà A, Fumaz CR, Ferrer MJ, Bayés R, Arnó A, Balagué M, Bonjoch A, Jou A, Negredo E, Paredes R, Ruiz L, Romeu J, Sirera G, Tural C, Burger D, Clotet B.

J Acquir Immune Defic Syndr. 2000 Nov 1;25(3):221-8.

PMID:
11115952
7.

Interventions to improve adherence to antiretroviral therapy in children with HIV infection.

Bain-Brickley D, Butler LM, Kennedy GE, Rutherford GW.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD009513. doi: 10.1002/14651858.CD009513. Review.

PMID:
22161452
8.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
9.

A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes.

Chung MH, Richardson BA, Tapia K, Benki-Nugent S, Kiarie JN, Simoni JM, Overbaugh J, Attwa M, John-Stewart GC.

PLoS Med. 2011 Mar;8(3):e1000422. doi: 10.1371/journal.pmed.1000422. Epub 2011 Mar 1.

10.

Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review.

Crepaz N, Hart TA, Marks G.

JAMA. 2004 Jul 14;292(2):224-36.

PMID:
15249572
11.

Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.

Johnson WD, Diaz RM, Flanders WD, Goodman M, Hill AN, Holtgrave D, Malow R, McClellan WM.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. doi: 10.1002/14651858.CD001230.pub2. Review.

PMID:
18646068
12.

Adherence-enhancing interventions for highly active antiretroviral therapy in HIV-infected patients - a systematic review.

Mathes T, Pieper D, Antoine SL, Eikermann M.

HIV Med. 2013 Nov;14(10):583-95. doi: 10.1111/hiv.12051. Epub 2013 Jun 17. Review.

13.

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.

Pai NP, Lawrence J, Reingold AL, Tulsky JP.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006148. Review.

PMID:
16856117
14.

Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.

Aziz N, Sokoloff A, Kornak J, Leva NV, Mendiola ML, Levison J, Feakins C, Shannon M, Cohan D.

BJOG. 2013 Nov;120(12):1534-47. doi: 10.1111/1471-0528.12226. Epub 2013 Aug 7.

15.

Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection.

Horvath T, Azman H, Kennedy GE, Rutherford GW.

Cochrane Database Syst Rev. 2012 Mar 14;3:CD009756. doi: 10.1002/14651858.CD009756. Review.

PMID:
22419345
16.

A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users.

Macalino GE, Hogan JW, Mitty JA, Bazerman LB, Delong AK, Loewenthal H, Caliendo AM, Flanigan TP.

AIDS. 2007 Jul 11;21(11):1473-7.

PMID:
17589194
17.
19.

Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials.

Finitsis DJ, Pellowski JA, Johnson BT.

PLoS One. 2014 Feb 5;9(2):e88166. doi: 10.1371/journal.pone.0088166. eCollection 2014.

20.

Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.

Young TN, Arens FJ, Kennedy GE, Laurie JW, Rutherford Gw.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002835. Review.

PMID:
17253483
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk